These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 28035395)
1. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells. Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395 [TBL] [Abstract][Full Text] [Related]
2. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide. Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021 [TBL] [Abstract][Full Text] [Related]
4. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. Ling Y; Wei K; Zou F; Zhong S Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964 [TBL] [Abstract][Full Text] [Related]
5. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
7. [Orthogonal experiments for optimizing the formulation and preparation conditions of temozolomide solid lipid nanoparticles]. Dou M; Huang G; Xi Y; Zhang N Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1141-5. PubMed ID: 19024463 [TBL] [Abstract][Full Text] [Related]
8. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465 [TBL] [Abstract][Full Text] [Related]
9. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548 [TBL] [Abstract][Full Text] [Related]
10. Dacarbazine nanoparticle topical delivery system for the treatment of melanoma. Hafeez A; Kazmi I Sci Rep; 2017 Nov; 7(1):16517. PubMed ID: 29184162 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757 [TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab. Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432 [TBL] [Abstract][Full Text] [Related]
13. [Preparation and in vitro evaluation of borneol and folic acid co-modified doxorubicin loaded PAMAM drug delivery system]. Li JJ; Guo MM; Han SP; Sun Y; Fei WD; Xu XI; Li FZ Yao Xue Xue Bao; 2015 Jul; 50(7):899-905. PubMed ID: 26552154 [TBL] [Abstract][Full Text] [Related]
14. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer. Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982 [TBL] [Abstract][Full Text] [Related]
15. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584 [TBL] [Abstract][Full Text] [Related]
16. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
17. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Irani M; Mir Mohamad Sadeghi G; Haririan I Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
19. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828 [TBL] [Abstract][Full Text] [Related]
20. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]